logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Communityacquired Pneumonia

    FiltersReset Filters
    45 results

    • azithromycin

      (AZITHROMYCIN MONOHYDRATE)
      Fresenius Kabi USA, LLC
      Usage: Azithromycin for injection is indicated for treating infections from specific susceptible bacteria, including community-acquired pneumonia and pelvic inflammatory disease, in patients needing initial intravenous therapy. It should be used judiciously to avoid drug-resistant bacteria and may be followed by oral Azithromycin as needed.

    • azithromycin

      (AZITHROMYCIN MONOHYDRATE)
      Lannett Company, Inc.
      Usage: Azithromycin is a macrolide antibacterial indicated for mild to moderate infections in adults and pediatrics, including respiratory infections, skin infections, and certain sexually transmitted infections. It should only be used when infections are confirmed or strongly suspected to be due to susceptible bacteria to prevent resistance.

    • azithromycin

      (azithromycin monohydrate)
      Sagent Pharmaceuticals
      Usage: Azithromycin for injection is indicated for treating infections from susceptible microorganisms, such as community-acquired pneumonia and pelvic inflammatory disease, requiring initial intravenous therapy. It should be used judiciously to combat drug-resistant bacteria, with consideration of culture data when available.

    • azithromycin

      (Azithromycin)
      Alembic Pharmaceuticals Limited
      Usage: Azithromycin is indicated for treating mild to moderate infections caused by susceptible bacteria, including acute bacterial exacerbations of chronic bronchitis, sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, skin infections, urethritis, cervicitis, and genital ulcer disease in men. Pediatric uses include acute otitis media and pneumonia in older children.

    • azithromycin

      (Azithromycin)
      Alembic Pharmaceuticals Inc.
      Usage: Azithromycin tablets are indicated for treating mild to moderate infections in adults and pediatric patients, including respiratory infections, skin infections, pharyngitis, and certain sexually transmitted infections. It is crucial to use azithromycin for infections caused by susceptible strains to prevent drug resistance.

    • baxdela

      (delafloxacin meglumine)
      Melinta Therapeutics, LLC
      Usage: BAXDELA is indicated for adults with acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia caused by specific susceptible microorganisms, including MRSA and various strains of Streptococcus and Enterobacter. It should be used to mitigate drug-resistant bacteria development.

    • cefdinir

      (cefdinir)
      Ascend Laboratories, LLC
      Usage: Cefdinir is indicated for treating mild to moderate infections caused by susceptible bacteria. This includes community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute maxillary sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections, in both adults and pediatric patients. It should only be used when bacterial susceptibility is confirmed or suspected.

    • cefdinir

      (Cefdinir)
      Lupin Pharmaceuticals Inc
      Usage: Cefdinir capsules are indicated for mild to moderate infections caused by susceptible bacteria, including community-acquired pneumonia, acute bronchitis exacerbations, acute maxillary sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections. The drug aims to prevent drug-resistant bacteria development and should be used based on culture and susceptibility data when available.

    • cefdinir

      (Cefdinir)
      Teva Pharmaceuticals USA, Inc.
      Usage: Cefdinir for oral suspension is indicated for treating mild to moderate infections caused by susceptible bacteria, including community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute maxillary sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections in both adults and pediatric patients.

    • cefdinir

      (Cefdinir)
      Lupin Pharmaceuticals Inc
      Usage: Cefdinir for oral suspension is indicated for treating mild to moderate infections caused by susceptible bacteria, including community-acquired pneumonia, acute bronchitis exacerbations, acute sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections. It should be used judiciously to prevent antibiotic resistance.